Increasing the fine particle fraction of pressurised metered dose inhaler solutions with novel actuator shapes.

Fine particle dose Fine particle fraction High-speed imaging Next generation impactor Solutions pMDI

Journal

International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127

Informations de publication

Date de publication:
15 Mar 2021
Historique:
received: 03 11 2020
revised: 20 01 2021
accepted: 31 01 2021
pubmed: 6 2 2021
medline: 22 6 2021
entrez: 5 2 2021
Statut: ppublish

Résumé

In this paper we demonstrate that the use of multiple orifices can improve the fine particle fraction (FPF) of pressurised metered-dose inhaler solution formulations by up to 75% when compared to a single orifice with an equivalent cross sectional area (p<0.05). While prior work has relied on metal actuator components, improvements in micro injection moulding and micro drilling now make it possible to mass produce novel orifice shapes to achieve similar FPF gains in plastic parts, with orifice diameters less than 0.2 mm. The ability to create internal features inside the actuator is also demonstrated. We show through in vitro high speed imaging that twin orifice sprays merge quickly and act as a single, modified plume. We also show for the first time that FPF and fine particle dose (FPD) are strongly correlated with the distance at which the plume velocity decays to half its initial value (R

Identifiants

pubmed: 33545289
pii: S0378-5173(21)00145-9
doi: 10.1016/j.ijpharm.2021.120341
pii:
doi:

Substances chimiques

Aerosols 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

120341

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

Daniel J Duke (DJ)

Laboratory for Turbulence Research in Aerospace & Combustion (LTRAC), Department of Mechanical & Aerospace Engineering, Monash University, Melbourne, Australia. Electronic address: daniel.duke@monash.edu.

Dung T Nguyen (DT)

Laboratory for Turbulence Research in Aerospace & Combustion (LTRAC), Department of Mechanical & Aerospace Engineering, Monash University, Melbourne, Australia.

Larissa Gomes Dos Reis (LG)

Respiratory Technology, Woolcock Institute of Medical Research and Discipline of Pharmacology, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.

Dina M Silva (DM)

Respiratory Technology, Woolcock Institute of Medical Research and Discipline of Pharmacology, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.

Adrian Neild (A)

Laboratory for Microsystems, Department of Mechanical & Aerospace Engineering, Monash University, Melbourne, Australia.

Daniel Edgington-Mitchell (D)

Laboratory for Turbulence Research in Aerospace & Combustion (LTRAC), Department of Mechanical & Aerospace Engineering, Monash University, Melbourne, Australia.

Paul M Young (PM)

Respiratory Technology, Woolcock Institute of Medical Research and Discipline of Pharmacology, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.

Damon R Honnery (DR)

Laboratory for Turbulence Research in Aerospace & Combustion (LTRAC), Department of Mechanical & Aerospace Engineering, Monash University, Melbourne, Australia.

Articles similaires

Aerosols Humans Decontamination Air Microbiology Masks
Humans Surgical Staplers Surgical Stapling Postoperative Complications Treatment Outcome
Animals Robotics Algorithms Sperm Whale Vocalization, Animal
Nanoparticles Needles Polylactic Acid-Polyglycolic Acid Copolymer Polyethylene Glycols Curcumin

Classifications MeSH